{"name":"CytoMed Therapeutics Pte Ltd","slug":"cytomed-therapeutics-pte-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1IWGt0aHk5LV9Ra2l3Z2FqQXB5am1RODZZaVIydHJvM2ZMX2R6bFJ4R0VGWjAwU25CdkYzY1VocnAwcGpTcnJTNXhYVU9zanB6Sk5pbE9NVk1OMURLeHM3VEdkWGRlcnPSAWxBVV95cUxOV05WRWNUVmU1Zy1QRzNXQlBwQjlUb2xieU91ekx1SmNQcXEwQ2dxVkxtaThLd21uUzFiaE1pWEVZVVJ3dUQ1RjNTelpyb3hyLVlHa3ZyT3Y5c0ZTQUM2MFRaTFNEYkp2X2E0N3c?oc=5","date":"2026-03-05","type":"pipeline","source":"BioInformant","summary":"The Pipeline for iPSC-Derived Cell Therapeutics in 2026 - BioInformant","headline":"The Pipeline for iPSC-Derived Cell Therapeutics in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNbl9teG5zTHg0NDB0MjVpYk11Y2tCWjFtZGo0RWtTdjBGS29TUEF4UmNQbnNERlFEbm9HX1N0N0JhVUd2SE9tMFAzZ1BiR0RlU25vLWpsUGNhcmhqVFhhMmlmcVNTeC1UUFltWmJ3eHVROTh5UkdFX1ZtYnhmWllnNkEzdVctNDBkc3VkRF8yQngyV1A2WFVzRDV6UTRSZw?oc=5","date":"2026-03-02","type":"pipeline","source":"twst.com","summary":"Interview with the Chairman: CytoMed Therapeutics Ltd. (NASDAQ:GDTC) - twst.com","headline":"Interview with the Chairman: CytoMed Therapeutics Ltd. (NASDAQ:GDTC)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPVWdGRTVzOWhMVlJyUkU3eXc2SjFDbl9lbm93VmphbEtwRXBybklIbjB1Njhvdk5KaXdDNkRURXdWaTlySWxaaUFuZVFjZlZPYVR4cWRNRkpzeUlKRjJsYVlUX0pIdWpsTkJRWlJLNm85ZHFZZG9ndHlSRy1xQXFNb3RWX0lpME9SOEJ1VFNCVzREWTA?oc=5","date":"2025-12-17","type":"pipeline","source":"Insightace Analytic","summary":"Novel T-Cell Immunotherapies Market Share, Size, Growth and Forecast to 2034 - Insightace Analytic","headline":"Novel T-Cell Immunotherapies Market Share, Size, Growth and Forecast to 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiTkFVX3lxTE1iMTgtdkNHNk1XeUF1dVAwd3R3SnhXVE1oc0JVenVaM3BUU0pCYTROWlp1OUk2UE9zcENVMlJJRkxZNUh1ZWZCZ0xkdmNvZ9IBU0FVX3lxTE5tNDNOY0lfdmF6ZnR3SHBYbGVfRnhjRXFOVnBZTGtxVklOdS14N3JleUlBQ1Z6U1NHU3RuWUxtX2o2TGc1WDduU2V5YmxSSWdzdVFR?oc=5","date":"2025-10-14","type":"pipeline","source":"BioInformant","summary":"iPSC Applications in Cell Therapy, Drug Discovery, and Beyond - BioInformant","headline":"iPSC Applications in Cell Therapy, Drug Discovery, and Beyond","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxPaUpjZWVBaHRGWXRIZ3Zibk1KT0pHaTNlUFd2aVhvaHZmSGFBcVBPeDVIdGQ1M2oyRVNWQ21wSVNqOXZseVNTX1lwU0lZcE9tbFVKVHlvVTUybzFiOFdHc1lialNhYXVmTHNzTHFRZGxRS1N3M2UzdUNDeXZvR3ZwTGJkdk1iaXJSWkVzT3NVZkUzWmJBM00tZEtuclVNMk52NUJqN1RGbjhCMjh1VmRRUmMtVElCZGtFZVI0UHd2bW81NmZjR3ZXZkZJY0JhWUtQZ0ZsbnpIbW11Q3BtQkhJeVhlQ1gwNFFlT2pzTFdZbVhJV3hkQTFVUktYQWdmSUJTSzdvbUFYT1Y1aW5UUHdEUW1jNy0wRU9Zb1R2MzJYNHZaeDhQODlYQkRDUG9kcExoa0dzWUxESktqY0hEMkZFQTVHQzJ2aGdKdURJUzNhMzA?oc=5","date":"2025-10-09","type":"regulatory","source":"Business Wire","summary":"Mesenchymal Stem Cells/Medicinal Signaling Cells Advances & Applications Report 2025: 1,670+ Trials, 12 Approvals Worldwide, and Path to 50 Approvals by 2040 - ResearchAndMarkets.com - Business Wire","headline":"Mesenchymal Stem Cells/Medicinal Signaling Cells Advances & Applications Report 2025: 1,670+ Trials, 12 Approvals Worldw","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE9obTBpQmJqWU80dTdIOGZic1hJUkU0ZUxzWFVVRTFIcmVEVmtabXZTUV9JVDR2eVk1aGRTcm8xaXRCV0U0dzNxM0JObTJEUVBMQmc?oc=5","date":"2023-08-28","type":"pipeline","source":"Yahoo Finance Singapore","summary":"CytoMed Therapeutics Limited (GDTC) stock price, news, quote and history - Yahoo Finance Singapore","headline":"CytoMed Therapeutics Limited (GDTC) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOTTZ4amFYVXNiTVJYdzhEVHk4ODZoQkpXRXhZblBlQTlNdEl5U3hrVWhOcUR5MnJjbnYxRVdJemZQVjB6SGEtc2ZURmE5TDZ1WFp5NUI3cnAtLW16RTltRUxBRHV5Y3VyOVoyQVVMQkJCcUNFUXdLV2hHOUJjUVJ0SWVIUHowbDhKMXRGTHRFQ0FWc0E3QmJvMnFlWWhjcWE4QXpZZklZc016aHFtOWVqRWhSa2tOeTJLV21GQVM1aHBWZk5XZU5vS1NYQm9tU2JtR1RyczZ3SnNGU1ZmeTh5V25jSUVsbmRpOEEzcHdIU01ZS1FxRUV0b3Jyeko?oc=5","date":"2023-08-15","type":"deal","source":"PR Newswire","summary":"CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency - PR Newswire","headline":"CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPSEtfaWw1ZEhDbl9SYlhaQ3o3RjdueW9IUHpUNVBMc3ZOVmJQZjJTbnEtZzNSRVNoeFVFbUhoS3RiZWwyeEI0SWk5WHlndWxRT0ktSl9vUnM0ekhyYmVBdW1tQXJvZktoNS11UVctQkV5YmFqdXU4a3gyYkVXUTA1UlNqNm5oc0dOM3djNFI0SHFJbThqSlB0bVVTTQ?oc=5","date":"2023-02-03","type":"pipeline","source":"Seeking Alpha","summary":"IPO Update: CytoMed Therapeutics Aims For $11 Million U.S. IPO (Pending:GDTC) - Seeking Alpha","headline":"IPO Update: CytoMed Therapeutics Aims For $11 Million U.S. IPO (Pending:GDTC)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}